Duke University
Duke University
Durham, North Carolina, United States45 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, diabetes mellitus, diabetic kidney disease, diabetic neuropathy, endocrine system disorder, kidney disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, urinary system disorder | Not yet recruiting | Phase 4 | 2026-09-28 | NCT07795593 | |
| Persona Ti-Nidium Post-Market Clinical Follow-up | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, polyarticular arthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2026-09-22 | NCT04817969 | |
| Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, urinary system disorder | Recruiting | Phase 3 | 2026-09-21 | NCT06798909 | |
| Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) | cardiovascular disorder, heart disorder, heart failure | Enrolling by invitation | Not applicable | 2026-09-21 | NCT06052072 | |
| Functional Incremental Stepping in Place Test (F-IST) Validation | Acute Care Medical; Intensive Care Medicine | Active, not recruiting | Not stated | 2026-09-15 | NCT06853236 | |
| Stress and Menstrual Health | Menstrual Dysfunction | Recruiting | Not applicable | 2026-09-09 | NCT07566260 | |
| Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial | Intraoperative Awareness, Intraoperative Complications, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not applicable | 2026-09-04 | NCT05991453 | |
| Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-09-03 | NCT06540963 | |
| Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-09-03 | NCT05846789 | |
| Neuroblastoma Maintenance Therapy Trial | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-03 | NCT02679144 | |
| X-linked Hypophosphatemia Disease Monitoring Program | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypophosphatemia, Familial, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Rickets, X-Linked Hypophosphatemic, Urogenital Diseases, X-linked hypophosphatemic rickets, bone disorder, calcium metabolic disease, hereditary disease, hypophosphatemia, hypophosphatemic rickets, inborn errors of metabolism, inborn metal metabolism disorder, kidney disorder, metabolic disease, musculoskeletal system disorder, nutritional deficiency disease, nutritional disorder, phosphorus metabolism disease, renal tubular transport disease, rickets, urinary system disorder, vitamin D deficiency, vitamin deficiency disorder | Active, not recruiting | Not stated | 2026-08-28 | NCT03651505 | |
| Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 3 | 2026-08-25 | NCT04084080 | |
| Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-08-24 | NCT07136623 | |
| Navigation Study: Durham | Prenatal; Postnatal | Active, not recruiting | Not applicable | 2026-08-21 | NCT04438031 | |
| Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-08-12 | NCT05489887 | |
| Prototyping a Device for Automating Stool and Urine Output Tracking | Waste Output | Recruiting | Not applicable | 2026-08-12 | NCT05438199 | |
| DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-08-12 | NCT04696029 | |
| Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction | Concentric Hypertrophy; Heart Failure With Preserved Ejection Fraction | Active, not recruiting | Not applicable | 2026-08-03 | NCT05839730 | |
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, facioscapulohumeral muscular dystrophy, facioscapulohumeral muscular dystrophy 1, facioscapulohumeral muscular dystrophy 2, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 3 | 2026-07-27 | NCT07038200 | |
| A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur | Fractures, Spontaneous, bone fracture, injury | Active, not recruiting | Not applicable | 2026-07-22 | NCT02164019 | |
| Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, facioscapulohumeral muscular dystrophy, facioscapulohumeral muscular dystrophy 1, facioscapulohumeral muscular dystrophy 2, frontometaphyseal dysplasia 2, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, progressive muscular dystrophy | Active, not recruiting | Phase 2 | 2026-07-14 | NCT06547216 | |
| Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia | Arthralgia, Chronic Pain, Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, arthropathy, breast cancer, breast disorder, breast neoplasm, musculoskeletal system disorder, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-07-08 | NCT05703178 | |
| Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-07-06 | NCT05685745 | |
| Combination Therapy for the Treatment of Diffuse Midline Gliomas | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, diffuse midline glioma, H3 K27M-mutant, epithelial neoplasm, glioma, grade III glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-06-26 | NCT05009992 | |
| Signatera Assessment in Early-Stage Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Not applicable | 2026-06-17 | NCT07339384 |